These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 142654)

  • 1. Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection.
    Masiello P; Bergamini E
    Experientia; 1977 Sep; 33(9):1246-7. PubMed ID: 142654
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes.
    Rakieten N; Gordon BS; Beaty A; Cooney DA; Schein PS; Dixon RL
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):356-61. PubMed ID: 175379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
    Lazarus SS; Shapiro SH
    Diabetes; 1973 Jul; 22(7):499-506. PubMed ID: 4146293
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide.
    Schein PS; Rakieten N; Cooney DA; Davis R; Vernon ML
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):514-8. PubMed ID: 4267772
    [No Abstract]   [Full Text] [Related]  

  • 7. The uptake in the pancreatic islets of nicotinamide, nicotinic acid and tryptophan and their ability to prevent streptozotocin diabetes in mice.
    Tjälve H; Wilander E
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):357-64. PubMed ID: 135465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.
    Schein PS; Cooney DA; Vernon ML
    Cancer Res; 1967 Dec; 27(12):2324-32. PubMed ID: 4295475
    [No Abstract]   [Full Text] [Related]  

  • 9. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
    Schein PS; Cooney DA; McMenamin MG; Anderson T
    Biochem Pharmacol; 1973 Oct; 22(20):2625-31. PubMed ID: 4357891
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.
    Yamamoto H; Okamoto H
    Biochem Biophys Res Commun; 1980 Jul; 95(1):474-81. PubMed ID: 6251809
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptozotocin-induced suppression of FAD-linked glycerophosphate dehydrogenase in pancreatic islets of adult rats.
    Rasschaert J; Malaisse WJ
    Biochem Int; 1991 Mar; 23(4):707-14. PubMed ID: 1831360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of the protection by nicotinamide against the action of diabetogenic nitrosoureas.
    Akpan JO
    Diabete Metab; 1988 Dec; 14(6):693-9. PubMed ID: 2977592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets.
    Bedoya FJ; Solano F; Lucas M
    Experientia; 1996 Apr; 52(4):344-7. PubMed ID: 8620938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ionizing radiation on the resistance of rat pancreatic beta cells to streptozotocin].
    Gatsko GG; Brilevskaia SI
    Radiobiologiia; 1993; 33(2):225-8. PubMed ID: 8502739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of streptozotocin on the pancreatic A cell function.
    Kazumi T; Yoshino G; Morita S; Baba S
    Endocrinol Jpn; 1979 Jun; 26(3):331-5. PubMed ID: 157872
    [No Abstract]   [Full Text] [Related]  

  • 17. Islet cell membrane alteration by diabetogenic drugs.
    Orci L; Amherdt M; Malaisse-Lagae F; Ravazzola M; Malaisse WJ; Perrelet A; Renold AE
    Lab Invest; 1976 May; 34(5):451-4. PubMed ID: 131879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
    Kishore A; Nampurath GK; Mathew SP; Zachariah RT; Potu BK; Rao MS; Valiathan M; Chamallamudi MR
    Chem Biol Interact; 2009 Feb; 177(3):242-6. PubMed ID: 19038238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.
    Masiello P; Novelli M; Fierabracci V; Bergamini E
    Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced glutamate decarboxylase activity in rat islet beta cells which survived streptozotocin-induced cytotoxicity.
    Ling Z; Malaisse-Lagae F; Malaisse WJ; Pipeleers D
    FEBS Lett; 1993 Jun; 324(3):262-4. PubMed ID: 8405362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.